Overcoming Japan’s ‘Galapagos Syndrome’ with Dr. Lei Liu, AstraZeneca Japan

Japanese business is often compared to the ecosystem on the Galapagos Islands: unique due to its isolation. Can changes in regulation provide a shot in the arm for Japan’s economy? Steve talks to Dr. Lei Liu from AstraZeneca Japan about some the challenges and opportunities being brought about by this period of rapid change.

Watch the video version on our Podcasts Page.

Learn more about I2.JP healthcare innovation platform run by AstraZeneca here.